Carsten Saft

7.3k total citations
145 papers, 4.2k citations indexed

About

Carsten Saft is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Carsten Saft has authored 145 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Cellular and Molecular Neuroscience, 94 papers in Neurology and 52 papers in Molecular Biology. Recurrent topics in Carsten Saft's work include Genetic Neurodegenerative Diseases (129 papers), Neurological disorders and treatments (83 papers) and Mitochondrial Function and Pathology (46 papers). Carsten Saft is often cited by papers focused on Genetic Neurodegenerative Diseases (129 papers), Neurological disorders and treatments (83 papers) and Mitochondrial Function and Pathology (46 papers). Carsten Saft collaborates with scholars based in Germany, Switzerland and United Kingdom. Carsten Saft's co-authors include Christian Beste, Jürgen Andrich, Michael Falkenstein, Larissa Arning, Ralf Gold, G. Bernhard Landwehrmeyer, Jörg T. Epplen, Peter H. Kraus, Stefan Wieczorek and Gisa Ellrichmann and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Carsten Saft

142 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carsten Saft Germany 40 2.6k 1.7k 1.7k 879 345 145 4.2k
Charles K. Meshul United States 39 2.7k 1.0× 1.5k 0.9× 1.7k 1.0× 516 0.6× 333 1.0× 130 4.9k
Doris J. Doudet Canada 34 1.5k 0.6× 747 0.4× 1.2k 0.7× 485 0.6× 428 1.2× 131 3.4k
Pierre J. Blanchet Canada 38 2.1k 0.8× 639 0.4× 2.4k 1.4× 590 0.7× 397 1.2× 112 3.9k
Marc Savasta France 39 3.4k 1.3× 966 0.6× 2.7k 1.6× 707 0.8× 167 0.5× 86 4.8k
Ralf Reilmann Germany 36 4.8k 1.9× 2.6k 1.5× 3.9k 2.3× 629 0.7× 472 1.4× 145 6.2k
Pekka Jäkälä Finland 30 1.3k 0.5× 667 0.4× 1.3k 0.8× 690 0.8× 325 0.9× 84 3.0k
Robert J. Ferrante United States 12 1.8k 0.7× 1.4k 0.8× 899 0.5× 466 0.5× 219 0.6× 16 2.9k
Baltazar Gomez‐Mancilla Switzerland 36 1.6k 0.6× 1.0k 0.6× 1.3k 0.8× 940 1.1× 464 1.3× 77 3.5k
Renato P. Munhoz Canada 35 1.6k 0.6× 766 0.4× 2.8k 1.6× 397 0.5× 457 1.3× 225 4.2k
Wendy R. Galpern United States 26 1.3k 0.5× 686 0.4× 1.3k 0.8× 502 0.6× 218 0.6× 51 2.8k

Countries citing papers authored by Carsten Saft

Since Specialization
Citations

This map shows the geographic impact of Carsten Saft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Saft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Saft more than expected).

Fields of papers citing papers by Carsten Saft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Saft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Saft. The network helps show where Carsten Saft may publish in the future.

Co-authorship network of co-authors of Carsten Saft

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Saft. A scholar is included among the top collaborators of Carsten Saft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Saft. Carsten Saft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oosterloo, Mayke, Lauren M. Byrne, Martha Nance, et al.. (2024). Clinical Review of Juvenile Huntington’s Disease. Journal of Huntington s Disease. 13(2). 149–161. 12 indexed citations
2.
Stodt, Benjamin, et al.. (2023). Factors Influencing the Total Functional Capacity Score as a Critical Endpoint in Huntington’s Disease Research. Biomedicines. 11(12). 3336–3336. 3 indexed citations
3.
Yu-Taeger, Libo, Arianna Novati, Jonasz Jeremiasz Weber, et al.. (2022). Evidences for Mutant Huntingtin Inducing Musculoskeletal and Brain Growth Impairments via Disturbing Testosterone Biosynthesis in Male Huntington Disease Animals. Cells. 11(23). 3779–3779. 4 indexed citations
4.
Matusch, Andreas, et al.. (2022). Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington’s Disease. Biomedicines. 10(6). 1258–1258. 2 indexed citations
5.
Saft, Carsten, et al.. (2022). Positive effect of immunomodulatory therapies on disease progression in Huntington’s disease? Data from a real-world cohort. Therapeutic Advances in Neurological Disorders. 15. 4213390838–4213390838. 3 indexed citations
6.
Richter, Daniel, Carsten Saft, & Lars Tönges. (2020). Emergence of Bruxism after Reducing Left Pallidal Stimulation in a Patient with Huntington's Disease. Movement Disorders Clinical Practice. 7(6). 704–705. 3 indexed citations
7.
Gelderblom, Hans, Torsten Wüstenberg, Wilhelm Fischer, et al.. (2017). Bupropion for the treatment of apathy in Huntington’s disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial. PLoS ONE. 12(3). e0173872–e0173872. 43 indexed citations
8.
Alkorta‐Aranburu, Gorka, Mikel Iriondo, Asier Fullaondo, et al.. (2015). Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene. PLoS ONE. 10(7). e0131573–e0131573. 10 indexed citations
9.
Skodda, Sabine, Uwe Schlegel, Rainer Hoffmann, & Carsten Saft. (2013). Impaired motor speech performance in Huntington’s disease. Journal of Neural Transmission. 121(4). 399–407. 30 indexed citations
10.
Saft, Carsten, et al.. (2013). CNR1 variation is associated with the age at onset in Huntington disease. European Journal of Medical Genetics. 56(8). 416–419. 15 indexed citations
11.
Saft, Carsten, et al.. (2013). Neues zur Huntington-Krankheit. Aktuelle Neurologie. 40(7). 377–392. 1 indexed citations
12.
Beste, Christian, Ann‐Kathrin Stock, Vanessa Ness, et al.. (2013). A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data. Scientific Reports. 3(1). 1797–1797. 21 indexed citations
13.
Burgunder, J‐M., Anna Rita Bentivoglio, David Craufurd, et al.. (2012). BETTER GLOBAL AND COGNITIVE FUNCTIONING FOR CHOREATIC COMPARED TO HYPOKINETIC-RIGID HUNTINGTON'S DISEASE. Journal of Neurology Neurosurgery & Psychiatry. 83.
14.
Saft, Carsten, Denis A. Akkad, Stefan Wieczorek, et al.. (2011). PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Molecular Neurodegeneration. 6(1). 32–32. 111 indexed citations
15.
Krogias, Christos, Jens Eyding, Ralf Gold, et al.. (2011). Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography. Journal of Psychiatry and Neuroscience. 36(3). 187–194. 51 indexed citations
16.
Arning, Larissa, Aiden Haghikia, Carsten Saft, et al.. (2010). Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. Journal of Molecular Medicine. 88(4). 431–436. 54 indexed citations
17.
Beste, Christian, Rita Willemssen, Carsten Saft, & Michael Falkenstein. (2009). Response inhibition subprocesses and dopaminergic pathways: Basal ganglia disease effects. Neuropsychologia. 48(2). 366–373. 165 indexed citations
18.
Andrich, Jürgen, et al.. (2007). Complex movement behaviour and progression of Huntington's disease. Neuroscience Letters. 416(3). 272–274. 23 indexed citations
19.
Wieczorek, Stefan, Carsten Saft, Jürgen Andrich, et al.. (2006). No association between polymorphisms in the BDNF gene and age at onset in Huntington disease. BMC Medical Genetics. 7(1). 79–79. 15 indexed citations
20.
Saft, Carsten, Jürgen Andrich, Peter H. Kraus, & H. Przuntek. (2005). Der Einsatz von Amisulprid bei Patienten mit Morbus Huntington. Psychiatrische Praxis. 32(7). 363–366. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles K. Meshul Breakdown of academic impact, for papers by Doris J. Doudet Breakdown of academic impact, for papers by Pierre J. Blanchet Breakdown of academic impact, for papers by Marc Savasta Breakdown of academic impact, for papers by Ralf Reilmann Breakdown of academic impact, for papers by Pekka Jäkälä Breakdown of academic impact, for papers by Robert J. Ferrante Breakdown of academic impact, for papers by Baltazar Gomez‐Mancilla Breakdown of academic impact, for papers by Renato P. Munhoz Breakdown of academic impact, for papers by Wendy R. Galpern
Rankless by CCL
2026